Stocks and Investing Stocks and Investing
Tue, March 17, 2020
[ 12:00 AM ] - WOPRAI
Brian Schwartz Maintained (WDAY) at Buy with Decreased Target to $165 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Ken Zerbe Maintained (SNV) at Buy with Decreased Target to $32 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
John Freeman Downgraded (VNOM) to Buy and Decreased Target to $12 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Ken Zerbe Maintained (VLY) at Hold with Decreased Target to $10 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Joseph Pantginis Downgraded (SSKN) to Hold on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Stephen Willey Maintained (SPRO) at Strong Buy with Decreased Target to $21 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
George Mihalos Upgraded (SQ) to Buy and Held Target at $70 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Brett Huff Maintained (SQ) at Buy with Decreased Target to $59 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Alex Rygiel Maintained (TMHC) at Strong Buy with Decreased Target to $23 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Courtney Yakavonis Maintained (TKR) at Hold with Decreased Target to $48 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Simeon Gutman Maintained (TGT) at Hold with Decreased Target to $110 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Alex Rygiel Maintained (TPC) at Strong Buy with Decreased Target to $17 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Alex Rygiel Downgraded (TPH) to Hold and Decreased Target to $11 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Simeon Gutman Maintained (ULTA) at Hold with Decreased Target to $250 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Nigel Dally Maintained (UNM) at Hold with Decreased Target to $18 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Joshua Pokrzywinski Maintained (WMS) at Hold with Decreased Target to $39 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Rupesh Parikh Upgraded (WMT) to Buy and Held Target at $42 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Simeon Gutman Maintained (WSM) at Sell with Decreased Target to $23 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Mark Zgutowicz Upgraded (WIX) to Hold and Held Target at $102 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Selman Akyol Maintained (WMB) at Strong Buy with Decreased Target to $25 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Celine Pannuti Maintained (CCEP) at Buy with Decreased Target to $45 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Alex Rygiel Maintained (CCS) at Strong Buy with Decreased Target to $28 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Ken Zerbe Maintained (CFR) at Sell with Decreased Target to $72 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Courtney Yakavonis Maintained (TEX) at Hold with Decreased Target to $22 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
David George Upgraded (TFC) to Buy and Held Target at $56 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Alex Rygiel Downgraded (TGLS) to Hold and Decreased Target to $4.5 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Josh Vogel Upgraded (TBI) to Strong Buy on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Alex Rygiel Maintained (BXC) at Strong Buy with Decreased Target to $9 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
George Farmer Upgraded (BPMC) to Buy and Increased Target to $89 on, Mar 17th, 2020
[ 12:00 AM ] - WOPRAI
Konstantinos Aprilakis Upgraded (BPMC) to Strong Buy and Held Target at $70 on, Mar 17th, 2020

Konstantinos Aprilakis Upgraded (BPMC) to Strong Buy and Held Target at $70 on, Mar 17th, 2020


Published on 2024-10-27 00:07:35 - WOPRAI, Konstantinos Aprilakis
  Print publication without navigation


Konstantinos Aprilakis of Deutsche Bank, Upgraded "Blueprint Medicines Corporation" (BPMC) to Strong Buy and Held Target at $70 on, Mar 17th, 2020.

Konstantinos has made no other calls on BPMC in the last 4 months.



There is 1 other peer that has a rating on BPMC. Out of the 1 peers that are also analyzing BPMC, 0 agree with Konstantinos's Rating of Hold.



This is the rating of the analyst that currently disagrees with Konstantinos

  • Andrew Berens of "Morgan Stanley" Maintained at Buy with Decreased Target to $103 on, Tuesday, February 18th, 2020
Contributing Sources